Lipoprotein-associated phospholipase A2 activity is associated with coronary artery disease and markers of oxidative stress
The Plax test is slowly gaining ground as a strong marker for CVD risk. This article further affirms this relationship and goes further, linking oxidative stress biomarkers, Plax and CVD, with almost 2.5 times the risk for CVD when both were present in the highest levels.